BRPI0804068A2 - composições para uso no escurecimento da pele - Google Patents

composições para uso no escurecimento da pele

Info

Publication number
BRPI0804068A2
BRPI0804068A2 BRPI0804068-0A BRPI0804068A BRPI0804068A2 BR PI0804068 A2 BRPI0804068 A2 BR PI0804068A2 BR PI0804068 A BRPI0804068 A BR PI0804068A BR PI0804068 A2 BRPI0804068 A2 BR PI0804068A2
Authority
BR
Brazil
Prior art keywords
skin
compositions
darkening
polymer
skin darkening
Prior art date
Application number
BRPI0804068-0A
Other languages
English (en)
Inventor
Lin Connie Baozhen
Richard Scarpa
Stanley S Shapiro
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BRPI0804068A2 publication Critical patent/BRPI0804068A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/95—Involves in-situ formation or cross-linking of polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIçõES PARA USO NO ESCURECIMENTO DA PELE. A presente invenção refere-se a um polímero para escurecimento da pele, O polímero compreende unidades repetitivas derivadas de precursores de melanina e co-monómeros de amina. O polímero pode ser combinado com veículos cosmeticamente aceitáveis para formar composições tópicas. A invenção também proporciona métodos de escurecimento da pele.
BRPI0804068-0A 2007-10-01 2008-09-30 composições para uso no escurecimento da pele BRPI0804068A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/865,218 US20090087395A1 (en) 2007-10-01 2007-10-01 Compositions for use in darkening the skin

Publications (1)

Publication Number Publication Date
BRPI0804068A2 true BRPI0804068A2 (pt) 2009-06-02

Family

ID=40361706

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0804068-0A BRPI0804068A2 (pt) 2007-10-01 2008-09-30 composições para uso no escurecimento da pele

Country Status (3)

Country Link
US (1) US20090087395A1 (pt)
EP (1) EP2045297A3 (pt)
BR (1) BRPI0804068A2 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573820B (zh) 2009-10-02 2015-11-25 强生消费者公司 包含抗炎共混物的组合物
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US20110081430A1 (en) 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US20110081305A1 (en) 2009-10-02 2011-04-07 Steven Cochran Compositions comprising a skin-lightening resorcinol and a skin darkening agent
WO2011073279A2 (fr) * 2009-12-18 2011-06-23 L'oreal Procédé de traitement cosmétique impliquant un composé apte à condenser in situ
FR2954142B1 (fr) * 2009-12-18 2012-04-13 Oreal Procede de traitement cosmetique impliquant un compose apte a condenser in situ
FR2954141B1 (fr) * 2009-12-18 2012-04-13 Oreal Procede pour capter des actifs dans la peau
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
US8414869B2 (en) 2010-11-30 2013-04-09 N.V. Perricone Llc Melanin promoting topical composition
FR2973690B1 (fr) * 2011-04-08 2013-03-29 Oreal Procede de coloration de la peau utilisant au moins un derive de 1,8-dihyroxy-naphtalene et au moins un agent oxydant chimique
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US9844757B2 (en) 2014-03-12 2017-12-19 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
TW201504140A (zh) 2013-03-12 2015-02-01 Lockheed Corp 形成具有均勻孔尺寸之多孔石墨烯之方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
CN106029596A (zh) 2014-01-31 2016-10-12 洛克希德马丁公司 采用多孔非牺牲性支撑层的二维材料形成复合结构的方法
CN105940479A (zh) 2014-01-31 2016-09-14 洛克希德马丁公司 使用宽离子场穿孔二维材料
JP2017534311A (ja) 2014-09-02 2017-11-24 ロッキード・マーチン・コーポレーション 二次元膜材料をベースとする血液透析膜および血液濾過膜、ならびにそれを用いた方法
JP2018528144A (ja) 2015-08-05 2018-09-27 ロッキード・マーチン・コーポレーション グラフェン系材料の穿孔可能なシート
WO2017023377A1 (en) 2015-08-06 2017-02-09 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
EP3442697A4 (en) 2016-04-14 2020-03-18 Lockheed Martin Corporation SELECTIVE INTERFACE REDUCTION OF GRAPH DEFECTS
WO2017180134A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
EP3442739A4 (en) 2016-04-14 2020-03-04 Lockheed Martin Corporation PROCESS FOR PROCESSING GRAPHENE SHEETS FOR LARGE SCALE TRANSFER USING A FREE FLOATING PROCESS
KR20180133430A (ko) 2016-04-14 2018-12-14 록히드 마틴 코포레이션 결함 형성 또는 힐링의 인 시츄 모니터링 및 제어를 위한 방법
EP3442786A4 (en) 2016-04-14 2020-03-18 Lockheed Martin Corporation TWO-DIMENSIONAL MEMBRANE STRUCTURES HAVING FLOW PASSAGES

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697118A (en) 1953-07-28 1954-12-14 Wyandotte Chemicals Corp Totally hydroxypropylated alkylene diamines
US4021538A (en) * 1975-09-29 1977-05-03 Yu Ruey J Method for producing pigmentation in hair or skin
US4690825A (en) 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5145675A (en) 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5227459A (en) 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5218079A (en) 1990-05-18 1993-06-08 Yale University Soluble melanin
US5216116A (en) 1990-05-18 1993-06-01 Yale University Soluble melanin
US5225435A (en) 1990-05-18 1993-07-06 Yale University Soluble melanin
US5744125A (en) 1993-08-19 1998-04-28 Yale University Cosmetic melanins
WO1995009629A1 (en) * 1993-10-01 1995-04-13 Yale University Synthetic melanin
US5702712A (en) * 1995-12-06 1997-12-30 Clairol, Incorporated Melanoquaternary compounds and their use as hair dyes and for skin treatment
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6797697B2 (en) 2001-05-21 2004-09-28 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7081442B2 (en) 2001-05-21 2006-07-25 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7025951B2 (en) 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
US7935331B2 (en) * 2003-12-12 2011-05-03 Johnson & Johnson Consumer Companies, Inc. Vanillin polymers for use in darkening the skin
US20060193818A1 (en) 2005-02-25 2006-08-31 Southall Michael D Compositions containing amines and use thereof
US20060193777A1 (en) * 2005-02-25 2006-08-31 Southall Michael D Method of screening compounds for potential efficacy for the treatment of signs of aging
US20070183994A1 (en) * 2006-02-03 2007-08-09 Toma's, L.L.C. Self-tanning product having slimming, firming and toning properties associated therewith

Also Published As

Publication number Publication date
EP2045297A3 (en) 2010-08-04
US20090087395A1 (en) 2009-04-02
EP2045297A2 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
BRPI0804068A2 (pt) composições para uso no escurecimento da pele
FR2930160B1 (fr) Ensemble de protection d'aiguille.
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
EP2144608A4 (en) SUN PROTECTION COMPOSITIONS AND METHODS
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
ES2534303T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
BRPI0820899A2 (pt) Formulação cosmética, e, uso da composição
IL232447A0 (en) Local topical administration formulations containing indoxacarb
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
BRPI0905663A2 (pt) "emulsão estável, processo de preparação da emulsão estável e uso emulsão"
WO2010002586A3 (en) Topical compositions comprising isonicotinamide
MX2010000465A (es) Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
WO2008089397A3 (en) Adrb2 cancer markers
UY28662A1 (es) Agente endoparasiticida para administracion topica
ECSP067093A (es) Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados
WO2010062581A3 (en) A botanical composition for enhanced skin repair and uses thereof
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
NI200900071A (es) Compuestos de pirozolina y su uso y composiciones farmacéuticas. pc 33496a.
CL2008001323A1 (es) Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
UY31922A (es) Compuestos
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 2004 DE 02/06/2009, QUANTO AO ITEM (71).

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 3A ANUIDADE.